Clinical Trials
110
Trial Phases
5 Phases
Drug Approvals
2
Clinical Trials
Distribution across different clinical trial phases (102 trials with phase data)• Click on a phase to view related trials
A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
- Conditions
- Osteoarthritis of Hip
- Interventions
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 32
- Registration Number
- NCT06977568
- Locations
- 🇺🇸
Medical Pain Management Services PLLC, Albany, New York, United States
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
- Conditions
- Osteoarthritis (OA) of the Knee
- Interventions
- Biological: Enekinragene Inzadenovec (PCRX-201)Biological: Placebo
- First Posted Date
- 2025-03-19
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 135
- Registration Number
- NCT06884865
- Locations
- 🇺🇸
Osteoporosis Medical Center, Beverly Hills, California, United States
🇺🇸Beach Physicians Medical Group Inc., Huntington Beach, California, United States
🇺🇸Horizon Clinical Research, La Mesa, California, United States
Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity
- Conditions
- Spasticity, Cerebral or Spinal Condition
- First Posted Date
- 2024-04-01
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 132
- Registration Number
- NCT06340451
- Locations
- 🇺🇸
Rancho Los Amigos National Rehabilitation Center, Downey, California, United States
🇺🇸Source Healthcare - Santa Monica, Santa Monica, California, United States
🇺🇸Nova Clinical Research, LLC, Bradenton, Florida, United States
ZILRETTA in Subjects With Shoulder Osteoarthritis
- Conditions
- Glenohumeral Osteoarthritis
- Interventions
- First Posted Date
- 2024-02-21
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 250
- Registration Number
- NCT06269705
- Locations
- 🇺🇸
Alabama Orthopaedic Center- Research, Vestavia Hills, Alabama, United States
🇺🇸Onyx Clinical Research, Surprise, Arizona, United States
🇺🇸Tucson Orthopaedic Institute (TOI) - East Office, Tucson, Arizona, United States
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery
- First Posted Date
- 2024-02-21
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 48
- Registration Number
- NCT06271265
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
🇺🇸University of Oklahoma (OU) - Medical Center - The Children's Hospital, Oklahoma City, Oklahoma, United States
🇺🇸The University of Texas Health Science Center at Houston (UTHSC-H) - McGovern Medical School, Houston, Texas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 21
- Next